Criteria for Causality: Bradford Hill Criteria - II
Pharmacovigilance
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Assumptions of Survival Analysis
Criteria for Causality: Bradford Hill Criteria - I
Hazard Ratio
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 6, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Tim Sullivan1, Magnus Nord2, Doug Domalik3
1Global Patient Safety Biopharma, Chief Medical Office, R&D, AstraZeneca, 200 Orchard Ridge Drive, Gaithersburg, MD, 20878, USA. tim.sullivan@astrazeneca.com.
A new Signal Assessment Guide (SAGe) tool offers a structured method for causality assessment of medicinal product safety signals. This framework enhances transparency and consistency in pharmacovigilance decision-making.
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: